Cancer-related fatigue, version 2.2015

Ann Malone Berger, Kathi Mooney, Amy Alvarez-Perez, William S. Breitbart, Kristen M. Carpenter, David Cella, Charles Cleeland, Efrat Dotan, Mario A. Eisenberger, Carmen P. Escalante, Paul B. Jacobsen, Catherine Jankowski, Thomas LeBlanc, Jennifer A. Ligibel, Elizabeth Trice Loggers, Belinda Mandrell, Barbara A. Murphy, Oxana Palesh, William F. Pirl, Steven C. Plaxe & 8 others Michelle B. Riba, Hope S. Rugo, Carolina Salvador, Lynne I. Wagner, Nina D. Wagner-Johnston, Finly J. Zachariah, Mary Anne Bergman, Courtney Smith

Research output: Contribution to journalArticle

141 Citations (Scopus)

Abstract

Cancer-related fatigue is defined as a distressing, persistent, subjective sense of physical, emotional, and/or cognitive tiredness or exhaustion related to cancer or cancer treatment that is not proportional to recent activity and interferes with usual functioning. It is one of the most common side effects in patients with cancer. Fatigue has been shown to be a consequence of active treatment, but it may also persist into posttreatment periods. Furthermore, difficulties in end-of-life care can be compounded by fatigue. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cancer-Related Fatigue provide guidance on screening for fatigue and recommendations for interventions based on the stage of treatment. Interventions may include education and counseling, general strategies for the management of fatigue, and specific nonpharmacologic and pharmacologic interventions. Fatigue is a frequently underreported complication in patients with cancer and, when reported, is responsible for reduced quality of life. Therefore, routine screening to identify fatigue is an important component in improving the quality of life for patients living with cancer.

Original languageEnglish (US)
Pages (from-to)1012-1039
Number of pages28
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume13
Issue number8
StatePublished - Aug 1 2015

Fingerprint

Fatigue
Neoplasms
Quality of Life
Terminal Care
Practice Guidelines
Counseling
Therapeutics
Guidelines
Education

ASJC Scopus subject areas

  • Oncology

Cite this

Berger, A. M., Mooney, K., Alvarez-Perez, A., Breitbart, W. S., Carpenter, K. M., Cella, D., ... Smith, C. (2015). Cancer-related fatigue, version 2.2015. JNCCN Journal of the National Comprehensive Cancer Network, 13(8), 1012-1039.

Cancer-related fatigue, version 2.2015. / Berger, Ann Malone; Mooney, Kathi; Alvarez-Perez, Amy; Breitbart, William S.; Carpenter, Kristen M.; Cella, David; Cleeland, Charles; Dotan, Efrat; Eisenberger, Mario A.; Escalante, Carmen P.; Jacobsen, Paul B.; Jankowski, Catherine; LeBlanc, Thomas; Ligibel, Jennifer A.; Loggers, Elizabeth Trice; Mandrell, Belinda; Murphy, Barbara A.; Palesh, Oxana; Pirl, William F.; Plaxe, Steven C.; Riba, Michelle B.; Rugo, Hope S.; Salvador, Carolina; Wagner, Lynne I.; Wagner-Johnston, Nina D.; Zachariah, Finly J.; Bergman, Mary Anne; Smith, Courtney.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 13, No. 8, 01.08.2015, p. 1012-1039.

Research output: Contribution to journalArticle

Berger, AM, Mooney, K, Alvarez-Perez, A, Breitbart, WS, Carpenter, KM, Cella, D, Cleeland, C, Dotan, E, Eisenberger, MA, Escalante, CP, Jacobsen, PB, Jankowski, C, LeBlanc, T, Ligibel, JA, Loggers, ET, Mandrell, B, Murphy, BA, Palesh, O, Pirl, WF, Plaxe, SC, Riba, MB, Rugo, HS, Salvador, C, Wagner, LI, Wagner-Johnston, ND, Zachariah, FJ, Bergman, MA & Smith, C 2015, 'Cancer-related fatigue, version 2.2015', JNCCN Journal of the National Comprehensive Cancer Network, vol. 13, no. 8, pp. 1012-1039.
Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D et al. Cancer-related fatigue, version 2.2015. JNCCN Journal of the National Comprehensive Cancer Network. 2015 Aug 1;13(8):1012-1039.
Berger, Ann Malone ; Mooney, Kathi ; Alvarez-Perez, Amy ; Breitbart, William S. ; Carpenter, Kristen M. ; Cella, David ; Cleeland, Charles ; Dotan, Efrat ; Eisenberger, Mario A. ; Escalante, Carmen P. ; Jacobsen, Paul B. ; Jankowski, Catherine ; LeBlanc, Thomas ; Ligibel, Jennifer A. ; Loggers, Elizabeth Trice ; Mandrell, Belinda ; Murphy, Barbara A. ; Palesh, Oxana ; Pirl, William F. ; Plaxe, Steven C. ; Riba, Michelle B. ; Rugo, Hope S. ; Salvador, Carolina ; Wagner, Lynne I. ; Wagner-Johnston, Nina D. ; Zachariah, Finly J. ; Bergman, Mary Anne ; Smith, Courtney. / Cancer-related fatigue, version 2.2015. In: JNCCN Journal of the National Comprehensive Cancer Network. 2015 ; Vol. 13, No. 8. pp. 1012-1039.
@article{f66cdcd69e9a4a3b8324ef7b5ada9bb3,
title = "Cancer-related fatigue, version 2.2015",
abstract = "Cancer-related fatigue is defined as a distressing, persistent, subjective sense of physical, emotional, and/or cognitive tiredness or exhaustion related to cancer or cancer treatment that is not proportional to recent activity and interferes with usual functioning. It is one of the most common side effects in patients with cancer. Fatigue has been shown to be a consequence of active treatment, but it may also persist into posttreatment periods. Furthermore, difficulties in end-of-life care can be compounded by fatigue. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cancer-Related Fatigue provide guidance on screening for fatigue and recommendations for interventions based on the stage of treatment. Interventions may include education and counseling, general strategies for the management of fatigue, and specific nonpharmacologic and pharmacologic interventions. Fatigue is a frequently underreported complication in patients with cancer and, when reported, is responsible for reduced quality of life. Therefore, routine screening to identify fatigue is an important component in improving the quality of life for patients living with cancer.",
author = "Berger, {Ann Malone} and Kathi Mooney and Amy Alvarez-Perez and Breitbart, {William S.} and Carpenter, {Kristen M.} and David Cella and Charles Cleeland and Efrat Dotan and Eisenberger, {Mario A.} and Escalante, {Carmen P.} and Jacobsen, {Paul B.} and Catherine Jankowski and Thomas LeBlanc and Ligibel, {Jennifer A.} and Loggers, {Elizabeth Trice} and Belinda Mandrell and Murphy, {Barbara A.} and Oxana Palesh and Pirl, {William F.} and Plaxe, {Steven C.} and Riba, {Michelle B.} and Rugo, {Hope S.} and Carolina Salvador and Wagner, {Lynne I.} and Wagner-Johnston, {Nina D.} and Zachariah, {Finly J.} and Bergman, {Mary Anne} and Courtney Smith",
year = "2015",
month = "8",
day = "1",
language = "English (US)",
volume = "13",
pages = "1012--1039",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "8",

}

TY - JOUR

T1 - Cancer-related fatigue, version 2.2015

AU - Berger, Ann Malone

AU - Mooney, Kathi

AU - Alvarez-Perez, Amy

AU - Breitbart, William S.

AU - Carpenter, Kristen M.

AU - Cella, David

AU - Cleeland, Charles

AU - Dotan, Efrat

AU - Eisenberger, Mario A.

AU - Escalante, Carmen P.

AU - Jacobsen, Paul B.

AU - Jankowski, Catherine

AU - LeBlanc, Thomas

AU - Ligibel, Jennifer A.

AU - Loggers, Elizabeth Trice

AU - Mandrell, Belinda

AU - Murphy, Barbara A.

AU - Palesh, Oxana

AU - Pirl, William F.

AU - Plaxe, Steven C.

AU - Riba, Michelle B.

AU - Rugo, Hope S.

AU - Salvador, Carolina

AU - Wagner, Lynne I.

AU - Wagner-Johnston, Nina D.

AU - Zachariah, Finly J.

AU - Bergman, Mary Anne

AU - Smith, Courtney

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Cancer-related fatigue is defined as a distressing, persistent, subjective sense of physical, emotional, and/or cognitive tiredness or exhaustion related to cancer or cancer treatment that is not proportional to recent activity and interferes with usual functioning. It is one of the most common side effects in patients with cancer. Fatigue has been shown to be a consequence of active treatment, but it may also persist into posttreatment periods. Furthermore, difficulties in end-of-life care can be compounded by fatigue. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cancer-Related Fatigue provide guidance on screening for fatigue and recommendations for interventions based on the stage of treatment. Interventions may include education and counseling, general strategies for the management of fatigue, and specific nonpharmacologic and pharmacologic interventions. Fatigue is a frequently underreported complication in patients with cancer and, when reported, is responsible for reduced quality of life. Therefore, routine screening to identify fatigue is an important component in improving the quality of life for patients living with cancer.

AB - Cancer-related fatigue is defined as a distressing, persistent, subjective sense of physical, emotional, and/or cognitive tiredness or exhaustion related to cancer or cancer treatment that is not proportional to recent activity and interferes with usual functioning. It is one of the most common side effects in patients with cancer. Fatigue has been shown to be a consequence of active treatment, but it may also persist into posttreatment periods. Furthermore, difficulties in end-of-life care can be compounded by fatigue. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cancer-Related Fatigue provide guidance on screening for fatigue and recommendations for interventions based on the stage of treatment. Interventions may include education and counseling, general strategies for the management of fatigue, and specific nonpharmacologic and pharmacologic interventions. Fatigue is a frequently underreported complication in patients with cancer and, when reported, is responsible for reduced quality of life. Therefore, routine screening to identify fatigue is an important component in improving the quality of life for patients living with cancer.

UR - http://www.scopus.com/inward/record.url?scp=84940102853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940102853&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 1012

EP - 1039

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 8

ER -